郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Agomelatine, an innovative pharmacological response to unmet needs.

期刊：Journal of psychopharmacology (Oxford, England)发表年份：2008作者：Y Le Strat; P Gorwood
阅读更多 →

药效评价The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

期刊：The international journal of biochemistry & cell biology发表年份：2008作者：Antje Moeller; Kjetil Ask; David Warburton; Jack Gauldie; Martin Kolb
阅读更多 →

药效评价Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats.

期刊：The Journal of neuroscience : the official journal of the Society for Neuroscience发表年份：2008作者：Carrie K Jones; Ashley E Brady; Albert A Davis; Zixiu Xiang; Michael Bubser; Mohammed Noor Tantawy; Alexander S Kane; Thomas M Bridges; J Phillip Kennedy; Stefania R Bradley; Todd E Peterson; M Sib Ansari; Ronald M Baldwin; Robert M Kessler; Ariel Y
阅读更多 →

药效评价S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and function

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2008作者：Mark J Millan; Clotilde Mannoury la Cour; Francesca Novi; Roberto Maggio; Valérie Audinot; Adrian Newman-Tancredi; Didier Cussac; Valérie Pasteau; Jean-A Boutin; Thierry Dubuffet; Gilbert Lavielle
阅读更多 →